-
Published 4/24/2026
Verkhratsky A, Lee CJ, Chun H, Göritz C, Harkany T, Lee JH, Lee S, Lindskog M, Koh W, Mulder J, Nam MH, Ottersen OP, Pekna M, Pekny M, Pekowska A, Ryu H, Sohn CH, Tretiakov EO, Untiet V, Viney TJ, Youn W, Yi C, Zorec R, Yun M, Cheong E, Nordberg A. Curing the brain: in search for new astrocyte-specific therapies. Exp Mol Med. 2026 Apr; 58(4):1086-1127. PMID: 42032208.
-
Published 4/9/2026
Darsono WHW, Hwang Y, Valencia E, Gunawan LT, Hyeon SJ, Ryu H, Stein TD, Chang MY, Wulansari N, Lee SH. Dysregulation of astrocytic DNAJC6 contributes to sporadic Parkinson's disease pathogenesis. J Clin Invest. 2026 Jun 01; 136(11). PMID: 41955024.
-
Published 2/5/2026
Kim HY, Kim S, Akaydin AN, Kim S, Hyeon SJ, Lee J, Ryu H. The rise of astrocytes: are they guardians or troublemakers of the brain disorder? Exp Mol Med. 2026 Mar; 58(2):301-318. PMID: 41639424.
-
Published 1/21/2026
Lee E, Park MY, Park M, Kim NY, Wei S, Hwang N, Ryu D, Ryu H, Park D, Lee G, Oh CM. Inhibition of de novo ceramide synthesis mitigates alpha-synuclein pathology in a Parkinson's disease mouse model. NPJ Parkinsons Dis. 2026 Jan 21; 12(1):49. PMID: 41559062.
-
Published 1/19/2026
Nguyen PTT, Yousefian-Jazi A, Hyeon SJ, Lee S, Kim SC, Park U, Jeong Y, Kim S, Kim S, Kim Y, Ryu HL, Lee KE, Stein TD, Myers RH, Hwang EM, Lee J, Ryu H. Astrocytic noncanonical WNT5B signaling modulates extracellular matrix remodeling and neuropathology in Huntington's disease. Signal Transduct Target Ther. 2026 Jan 19; 11(1):23. PMID: 41549079.